NO900186D0 - Kondenserte benzazepiner. - Google Patents

Kondenserte benzazepiner.

Info

Publication number
NO900186D0
NO900186D0 NO1990900186A NO900186A NO900186D0 NO 900186 D0 NO900186 D0 NO 900186D0 NO 1990900186 A NO1990900186 A NO 1990900186A NO 900186 A NO900186 A NO 900186A NO 900186 D0 NO900186 D0 NO 900186D0
Authority
NO
Norway
Prior art keywords
benzazepiner
condensed
useful
benzazepines
hypertension
Prior art date
Application number
NO1990900186A
Other languages
English (en)
Other versions
NO177264B (no
NO177264C (no
NO900186L (no
Inventor
Joel Gilbert Berger
Wei Kong Chang
Elijah Herman Gold
John Welch Clader
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO900186D0 publication Critical patent/NO900186D0/no
Publication of NO900186L publication Critical patent/NO900186L/no
Publication of NO177264B publication Critical patent/NO177264B/no
Publication of NO177264C publication Critical patent/NO177264C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO900186A 1987-07-15 1990-01-12 Analogifremgangsmåte for fremstilling av terapeutisk aktive, kondenserte benzazepiner, samt forbindelser for anvendelse som mellomprodukter ved analogifremgangsmåten NO177264C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/001636 WO1989000561A1 (en) 1987-07-15 1987-07-15 Fused benzazepines
EP87110253A EP0299101B1 (en) 1987-07-15 1987-07-16 Fused benzazepines

Publications (4)

Publication Number Publication Date
NO900186D0 true NO900186D0 (no) 1990-01-12
NO900186L NO900186L (no) 1990-01-12
NO177264B NO177264B (no) 1995-05-08
NO177264C NO177264C (no) 1995-08-16

Family

ID=26108265

Family Applications (1)

Application Number Title Priority Date Filing Date
NO900186A NO177264C (no) 1987-07-15 1990-01-12 Analogifremgangsmåte for fremstilling av terapeutisk aktive, kondenserte benzazepiner, samt forbindelser for anvendelse som mellomprodukter ved analogifremgangsmåten

Country Status (13)

Country Link
EP (2) EP0363353B1 (no)
JP (1) JPH0678317B2 (no)
AT (1) ATE78467T1 (no)
AU (1) AU617651B2 (no)
DE (1) DE3780649T2 (no)
DK (1) DK162889C (no)
ES (1) ES2043623T3 (no)
FI (1) FI93212C (no)
GR (1) GR3006671T3 (no)
HU (1) HU203537B (no)
NO (1) NO177264C (no)
WO (1) WO1989000561A1 (no)
ZA (1) ZA875183B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) * 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
PL168787B1 (pl) * 1989-08-03 1996-04-30 Smithkline Beecham Biolog Sposób wytwarzania czastki kompozytowej PL
ATE126511T1 (de) * 1990-02-02 1995-09-15 Schering Corp 4,5-cycloalkano-3-benzazepin-7-ol-derivate und ihre verwendung.
JPH07137816A (ja) * 1993-11-15 1995-05-30 Tokai Univ 地下空洞内貯蔵装置
CN1688584A (zh) * 2002-08-29 2005-10-26 先灵公司 治疗肥胖和中枢神经系统疾病的选择性d1/d5受体拮抗剂
EP1646623A2 (en) * 2003-05-22 2006-04-19 Schering Corporation 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
HU199805B (en) * 1986-01-16 1990-03-28 Schering Corp Process for producing condensed benzazepine derivatives and pharmaceutical compositions comprising such compounds

Also Published As

Publication number Publication date
DK162889B (da) 1991-12-23
HU203537B (en) 1991-08-28
NO177264B (no) 1995-05-08
NO177264C (no) 1995-08-16
ATE78467T1 (de) 1992-08-15
AU8037887A (en) 1989-02-13
JPH0678317B2 (ja) 1994-10-05
GR3006671T3 (no) 1993-06-30
DK9390A (da) 1990-03-12
EP0363353A1 (en) 1990-04-18
NO900186L (no) 1990-01-12
DE3780649D1 (de) 1992-08-27
EP0363353B1 (en) 1992-07-22
FI93212B (fi) 1994-11-30
WO1989000561A1 (en) 1989-01-26
ZA875183B (en) 1988-04-08
FI900175A0 (fi) 1990-01-12
DK9390D0 (da) 1990-01-12
AU617651B2 (en) 1991-12-05
JPH02504629A (ja) 1990-12-27
EP0299101B1 (en) 1992-09-23
FI93212C (fi) 1995-03-10
DE3780649T2 (de) 1992-12-10
ES2043623T3 (es) 1994-01-01
DK162889C (da) 1992-05-11
EP0299101A1 (en) 1989-01-18

Similar Documents

Publication Publication Date Title
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
DE3887625T2 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
WO1987004430A3 (en) Fused benzazepines
DE3885366D1 (de) Verfahren zur Herstellung von Pyrrolo-(3,4-c)pyrrolen.
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
NO20013941D0 (no) Polynukleotider med forkortet kjede og fremgangsmate ved fremstillingen derav
PT80752B (pt) Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas
MX9302414A (es) Proceso para la fabricacion de pirrolidinas (s)-3-amino-1- substituidas.
DK9390D0 (da) Kondenserede benzapiner
DE59510180D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
DE69018755T2 (de) Verfahren zur Herstellung von 3-(L-Pyroglutamyl)-L-thiazolidin-4-carbonsäure-Derivaten.
DK598687A (da) Detergentkomposition
DE69012882T2 (de) Herstellung von Stickstoffzusammensetzungen.
DE59103040D1 (de) Verfahren zur Herstellung von symmetrischen 2,2'-Methylen-bis-benztriazolylphenolen.
DE69107897T2 (de) Verfahren zur Herstellung von N,N'-bis(tetrabromophthalimid).
DE59812284D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
DE69425405D1 (de) Verbessertes Verfahren zur Herstellung von 2,4-di(alkylamine)-6-alkylthio-s-Triazinen und 2,4-alkylamine-4,6-di(alkylthio)-s-Triazinen
ES549983A0 (es) Procedimiento para preparar 6-sustituido-5-feniltetrazol (1,5-a)-(1,2,4)triazol-(1,5-c)pirimidinas
DE69015411D1 (de) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.
DE69802312D1 (de) Verfahren zur Herstellung von 3,3',5,5'-Tetra-b-Butylbiphenol
DE58906998D1 (de) Verfahren zur Herstellung von 4,5,6-Trichlorpyrimidin.
GR3020597T3 (en) Phospholipids for the treatment of multiple sclerosis
KR880701228A (ko) 2- 메틸-1,4- 디히드로피리딘, 그의 제조방법 및 이 화합물을 함유하는 제약 조성물